Pharma Journalist -

Dr. Reddy’s Laboratories Ltd and its subsidiary, Promius Pharma, LLC announced the filing of New Drug Application (NDA) for its migraine candidate DFN-02 with the U.S. Food and Drug…
Read More...

Synlogic announced that the first patient was dosed in its Phase 1b/2a clinical trial of SYNB1020. SYNB1020 is a Synthetic Biotic medicine being developed for the treatment of…
Read More...

Ahead of 18th annual Pain Therapeutics Conference (London, 21 - 22 May) SMi Group recently have caught up with Neil Singla, Founder & Chief Scientific Officer at Lotus Clinical…
Read More...

PharmAbcine announced that U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its leading clinical compound TTAC-0001 for “treatment of Glioblastoma…
Read More...

Martin Pharmaceuticals, a clinical stage pharmaceutical company focused on repurposing already-approved drugs to offer life-changing advances to patients afflicted with rare (orphan)…
Read More...

Aditlys is the first medical technology firm to develop a bioresorbable vascular access solution for patients undergoing dialysis treatment for chronic kidney disease. Aditlys’…
Read More...

Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy (ATTR-ACT) study evaluating tafamidis for the treatment of transthyretin cardiomyopathy met its primary…
Read More...

Abide Therapeutics announced that it has granted Celgene an exclusive worldwide license for ABX-1772, a preclinical drug candidate discovered by Abide. In connection with the license,…
Read More...

SMi Group reports: With updates on the recent developments in the Pre-Filled Syringes industry, and the ever-increased net worth of the medical devices market within the US…
Read More...

Clinipace Worldwide has announced the appointment of Ian Fraser as senior vice president of operations for the European Union and Middle East (EUME). In his new role, Fraser will lead…
Read More...